Why are researchers punching into people’s skin if they are on a quest for knowledge about the brain? What does the birth of new brain cells do for memory? Plus can a ‘tumour paint’ be developed to help beat brain cancer? And can we shed those post Christmas extra inches by doing difficult maths problems, instead of hitting the treadmill?
University of Oxford is the academic lead institution for StemBANCC. This 5 year project, which involves academic and industry partners across 11 countries, brings together internationally renowned scientists and clinicians to study and develop new therapies for 8 major diseases of our time: Alzheimer’s, Parkinson’s, Autism, Schizophrenia, Bipolar, Migraine, Pain and Diabetes. Its objective is to develop human-induced pluripotent stem cells as a platform for drug discovery.
OPDC have pioneered a technique that turns pieces of skin into pieces of brain. It's part of a large scale study to create a "bank" of artificially grown brain cells. This BBC news video explains more.
OPDC have begun creating a bank of artificially grown brain cells from Parkinson's patients which will enable researchers to study how the disease develops in unprecedented detail. They are using a new stem cell technique that allows them to turn a small piece of skin from the patient into a small piece of brain. This is the first time this has been done in a large-scale study aimed at finding cures for Parkinson's.
OPDC researchers have succeeded in using stem cell technology to grow nerve cells in the laboratory from initial skin samples taken from people with Parkinson’s. It’s the first large-scale effort of its kind in the UK.
We are looking for up to 300 male volunteers, ideally aged between 50 and 75, who are healthy with no family history of Parkinson’s. Ideally they should be English speaking with no sleep or memory issues. The study is investigating whether it is possible to detect and diagnose Parkinson’s earlier. It is running for the next five years. Dr Michele Hu, cohort study lead said: “One of the earliest phases of Parkinson’s, what we call the prodromal ...